Advances in Bioscience and Biotechnology

Advances in Bioscience and Biotechnology

ISSN Print: 2156-8456
ISSN Online: 2156-8502
www.scirp.org/journal/abb
E-mail: abb@scirp.org
"Antibody fragments: Prolonging circulation half-life special issue-antibody research"
written by Annabelle Patricia Herrington-Symes, Monika Farys, Hanieh Khalili, Steve Brocchini,
published by Advances in Bioscience and Biotechnology, Vol.4 No.5, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Current approaches of nanomedicines in the market and various stage of clinical translation
Acta Pharmaceutica Sinica B, 2022
[2] A Non-radiometric Approach to Determine Tissue Vascular Blood Volume in Biodistribution Studies
Moosavi, M Soto - The AAPS Journal, 2022
[3] Development and photophysical investigations of maleimide chromophores for applications in photoactive bioconjugates
2022
[4] Cloning and expression of antibody fragment (Fab) I: Effect of expression construct and induction strategies on light and heavy chain gene expression
Biochemical …, 2021
[5] Methods to generate site-specific conjugates of antibody and protein
Bioorganic & Medicinal Chemistry, 2021
[6] Human Single-Chain Antibodies That Neutralize Elastolytic Activity of Pseudomonas aeruginosa LasB
2021
[7] Designing and Development of a Tandem Bivalent Nanobody against VEGF165
2021
[8] Zielgerichtete Wirkstoffe für die Krebstherapie: Aktuelle Entwicklungen und Perspektiven
2021
[9] Considerations for the design of antibody-based therapeutics
2020
[10] An Overview of the Current ADC Discovery Landscape
2020
[11] Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives
2020
[12] Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics
2020
[13] Homogenous Scavenging Resolves Low-Purification Yield/Selectivity Caused by Secondary Binding of Protein-A to Antigen-Binding Antibody Fragments
2019
[14] Analysis of critical quality attributes in monoclonal antibodies for upstream process development
2019
[15] Combining the best of two worlds: Highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells
2019
[16] Overview of Antibody Drug Delivery.
2018
[17] Next Generation Biopharmaceuticals: Product Development
New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins, 2018
[18] Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells
Journal of Drug Delivery Science and Technology, 2018
[19] Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source
Enzyme and Microbial Technology, 2018
[20] Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs
Bioconjugate Chemistry, 2018
[21] Overview of Antibody Drug Delivery
Pharmaceutics, 2018
[22] Sélection de fragments d'anticorps dirigés contre les microcystines pour la mise au point de tests d'immunodétection
Thèse, 2018
[23] Antibody fragments as potential biopharmaceuticals for cancer therapy: success and limitations
2018
[24] Affimer-based impedimetric biosensors: the new analytical platform for biorecognition applications
2018
[25] Oral Bioavailability and Lymphatic Transport of Pueraria Flavone-Loaded Self-Emulsifying Drug-Delivery Systems Containing Sodium Taurocholate in Rats.
2018
[26] PPI Dendronized Gold Nanoparticles for Drug Delivery Applications: Synthesis, Characterization and Biological Evaluation
2018
[27] Synthesis of Fc peptides and glycopeptides to be used as internal standards for absolute quantitation of glycoforms of two human IgG subclasses by MALDI-MS …
2017
[28] Self aggregation of IgG fragments from different perspectives
2017
[29] Antibody Half‐Life
Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development, 2017
[30] Fc Engineering for developing therapeutic bispecific antibodies and novel scaffolds
Frontiers in immunology, 2017
[31] Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
Scientific Reports, 2017
[32] Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties
South African Journal of Clinical Nutrition, 2017
[33] Ligand-Targeted Drug Delivery
Chemical Reviews, 2017
[34] Microbial platform technology for recombinant antibody fragment production: A review
Geocarto International, 2016
[35] Approach for Half-Life Extension of Small Antibody Fragments That Does Not Affect Tissue Uptake
Bioconjugate Chemistry, 2016
[36] Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid-and Calcineurin Inhibitor-Free Future?
Drugs, 2016
[37] Antibody Half‐Life: Engineering for Optimal Performance
Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development, 2016
[38] Evaluation of pharmacokinetics and pharmacodynamics and clinical efficacy of certolizumab pegol for Crohn's disease
Expert opinion on drug metabolism & toxicology, 2015
[39] Antibody Fragments and Their Purification by Protein L Affinity Chromatography
Antibodies, 2015
[40] Encapsidated Atom-Transfer Radical Polymerization in Qβ Virus-like Nanoparticles
ACS nano, 2014
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top